Alencure Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 4.00 Cr
as on 16-11-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.37 Cr
as on 16-11-2024
- Revenue 48.84%
(FY 2023)
- Profit 68.66%
(FY 2023)
- Ebitda 136.40%
(FY 2023)
- Net Worth 37.08%
(FY 2023)
- Total Assets 13.69%
(FY 2023)
About Alencure Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company currently has active open charges totaling ₹22.37 Cr.
Jitender Singh, Abhiraj Sandhu, and Kuldeep Sandhu serve as directors at the Company.
- CIN/LLPIN
U33110HP2016PTC006229
- Company No.
006229
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 May 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Sirmaur, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alencure Biotech Private Limited offer?
Alencure Biotech Private Limited offers a wide range of products and services, including Material Testing Labs & Services, Environmental Testing Services, Nutraceuticals & Dietary Supplements, Mineral Supplement, Ayurvedic,Herbal Products & Medicine, Herbal Capsules, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Aceclofenac Tablet, Aceclofenac Paracetamol Serratiopeptidase Tablet.
Who are the key members and board of directors at Alencure Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitender Singh  | Director | 24-May-2016 | Current |
| Abhiraj Sandhu | Director | 24-May-2016 | Current |
| Kuldeep Sandhu | Additional Director | 24-Jun-2024 | Current |
Financial Performance of Alencure Biotech.
Alencure Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.84% increase. The company also saw a substantial improvement in profitability, with a 68.66% increase in profit. The company's net worth Soared by an impressive increase of 37.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alencure Biotech?
In 2023, Alencure Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alenvision Pharma Private LimitedActive 4 years 6 monthsJitender Singh and Abhiraj Sandhu are mutual person
- Alenrise Retail Private LimitedActive 3 years 5 months
Jitender Singh and Abhiraj Sandhu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Mar 2024 | ₹5.90 M | Open |
Others Creation Date: 12 Feb 2024 | ₹3.45 M | Open |
Hdfc Bank Limited Creation Date: 25 May 2022 | ₹0.24 M | Open |
How Many Employees Work at Alencure Biotech?
Alencure Biotech has a workforce of 16 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alencure Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alencure Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
